Google may not be losing the AI race — it may be refusing to play the same game.

That’s the real thesis.

While OpenAI and Anthropic keep pushing the classic bet — bigger models, more chips, more data, more scaling — Google seems to be running a two-front strategy.

Front one:
🟢 keep Gemini competitive enough to defend Search, Workspace, and Cloud

Front two:
🟢 invest in whatever comes after transformers if pure scaling starts to plateau

That second front is the interesting one.

Instead of betting everything on one giant monolithic LLM, Google is spreading chips across:

• world models
• embodied agents / robotics
• alternative intelligence architectures
• DeepMind’s scientific AI stack
• longer-horizon bets like Project Pi

The logic is brutal and simple:

if scaling laws keep working, Google survives with Gemini.
If scaling laws hit a wall, Google may be one of the few labs already building the escape routes.

That’s why Google can look “behind” in the benchmark war while still being strategically dangerous.

OpenAI and Anthropic are optimizing for:

• the next model release
• the next coding agent leap
• the next product cycle

Google may be optimizing for:

• the next paradigm

🗒 The market reads Google as slow because it’s comparing quarterly products. But the smarter read may be this: Google is not trying to win the current LLM race cleanly — it’s trying to still be alive, and maybe dominant, after the current race stops mattering.

Your phone is becoming a full AI coding terminal.

That’s the pitch behind HAPI.

It turns a smartphone into a control layer for AI coding tools, so you can keep building from mobile instead of being chained to a laptop.

What it claims to support:
🟢 Claude Code
🟢 Codex
🟢 Cursor Agent
🟢 Grok Build
🟢 OpenCode

What makes it interesting:
🟣 manage multiple coding agents from one place
🟣 use voice to control them
🟣 inspect files, edit code, and work in terminal flows from mobile
🟣 continue sessions started on desktop
🟣 even operate it through Telegram

That’s the real shift.

AI coding is no longer just “open laptop, open IDE.”
The interface is getting detached from the machine.

Once that happens, your phone stops being a distraction device and starts becoming a portable agent console.

🗒 The biggest change in coding may not be better models. It may be that the command center for those models shrinks into your pocket.

Hapi.run

Short-form video may literally switch off your brain’s “stop” network.

Researchers found that watching preferred short videos was linked to deactivation in two key regions for cognitive control:
🟢 dorsal anterior cingulate cortex (dACC)
🟢 dorsolateral prefrontal cortex (dlPFC)

Those are the circuits involved in:

• self-control
• attention regulation
• deciding to stop
• resisting impulses

In plain English:

your brain’s braking system gets quieter while you keep scrolling.

The nastier part is that this effect was stronger when people watched videos they actually liked and watched all the way through.

The study also linked the effect to neurochemistry:
🟣 higher resting glutamate in the dACC was associated with stronger suppression of control regions
🟣 connectivity between control regions increased during viewing, especially for preferred clips

So this is not just “TikTok is distracting.”

It may be:
short-form content is uniquely good at pulling the brain away from control mode and into passive reward mode.

Important caveat:
🟠 this does not mean short videos cause permanent brain damage
🟠 it does not prove every viewer loses self-control the same way
🟠 but it does suggest the medium is interacting directly with the circuits that help you stop

🗒 The real danger of short-form video may not be wasted time. It may be that the more it grips you, the less access your brain has to the part that says: enough.

Claude designed real protein binders for 14 of 15 targets — and that’s the first time this starts looking less like AI hype and more like drug R&D.

Anthropic just showed early lab results where Claude autonomously designed protein molecules for 15 biological targets, including cancer-relevant ones like PD-L1, EGFR, and VEGF-A.

The key number:
🟢 354 of 1320 constructs bound successfully in lab tests
🟢 that’s 26.8% hit rate overall
🟢 in the best setup, success reached 35.1%
🟢 typical industry baseline is often closer to 10–15%

That’s why this matters.

These were not just tokens on a screen.

The molecules were actually:
• designed by Claude
• synthesized in real life
• independently tested by Adaptyv Bio and Twist Bioscience

Important caveat:
this is still only the first gate.

Binding to a target is not the same as:
🟠 curing disease
🟠 being safe
🟠 surviving delivery in the body
🟠 working in animals
🟠 passing human trials

So no, Claude did not “cure cancer.”

But it may already be compressing weeks or months of early protein-design work into hours.

🗒 Dario Amodei said trust in AI will return not through ads, but through something like curing cancer. This is not that moment yet — but it may be the first time the path stops looking ridiculous.

Google may have found a way to estimate cardiometabolic risk with just a smartphone photo.

That’s much bigger than another health app feature.

Google researchers say smartphone imagery can go beyond BMI and estimate things tied to cardiometabolic risk — the cluster behind heart disease, diabetes, and metabolic decline.

Why this matters:

BMI is cheap, universal, and often misleading.

It tells you almost nothing about:

• fat distribution
• hidden metabolic risk
• body composition differences
• whether two people with the same weight are actually equally healthy

Google’s direction is more interesting:
use everyday device cameras to infer risk markers that normally need more friction to track.

Now imagine this gets plugged into:
🟢 Google Fit
🟢 Pixel phones
🟢 smartwatches
🟢 Android health dashboards

Then the product stops being “one more metric.”

It becomes a constant behavioral mirror.

And that could matter a lot.

Because most people don’t train from abstract fear of future disease.

They train when feedback becomes:
• immediate
• personal
• visual
• hard to ignore

If your phone starts showing that your cardiometabolic risk is drifting the wrong way, some people probably will train more.
And more importantly, they may train better, because the goal becomes clearer than “lose a bit of weight.”

The catch:
🟠 prediction is not diagnosis
🟠 risk scoring can create anxiety, false confidence, or obsession
🟠 and whether people actually change behavior depends on product design, not just model accuracy

🗒 If Google adds this to Fit and its devices, the real breakthrough won’t be the model. It will be turning passive gadgets into a daily metabolic feedback system.
And if you want to track your biological age already today, try AgePilot bot: https://t.me/AgePilotBot?start=ref_134163805

People love one number: “biological age 38.”
A new study looked at thousands of real tissue samples. Same person. Different organs. Different ages.
Blood already hints which organ is running ahead:
🟢 stroke → older brain
🟢 gut disease → older gut
That’s why a single score was always a bit of a lie.
CONCLUSION: stop chasing one number.
If memory is slipping, protect sleep and walks. If it’s the heart, that’s blood pressure and ApoB — not another pill.
https://www.nature.com/articles/s41591-026-04566-5

$101 million on the table. The job: make a 70-year-old function like 60 in twelve months.

XPRIZE picked 20 teams. Ten got $1 million.

The surprise: sci-fi cell reprogramming did not make the shortlist. Telehealth, stem cells, and boring existing drugs did.

CONCLUSION: until someone actually wins, you still need a baseline. Run AgePilot:
https://t.me/AgePilotBot?start=ref_134163805

Which would you buy back first — muscle, memory, or immunity?

https://www.xprize.org/prizes/healthspan

Most anti-aging content is a shopping list.

Pills. Protocols. A new stack every week.

The unsexy data has not changed:
🟢 walk most days
🟢 lift twice a week
🟢 sleep like it is a drug
🟢 eat enough protein
🟢 know your ApoB, not just cholesterol

CONCLUSION: if a protocol needs a suitcase of capsules, it is for the seller. Do one boring thing this week.

What’s yours?

MIT is pushing a radical idea: the brain may work less like a computer and more like a wave machine.

That’s the core of the new theory.

For decades, the dominant metaphor was simple:
neurons fire, synapses store information, the brain computes like a biological network.

MIT’s argument is sharper:

thought, action, and even consciousness may emerge from analog computations performed by traveling electrical waves across the cortex.

In other words, brain waves may not be a side effect.

They may be the actual computational mechanism.

Why this matters:
🟢 synapses can store memory and knowledge
🟢 but storage alone does not explain how the brain pulls the right thing out in milliseconds
🟢 wave dynamics may be the missing layer that organizes and mobilizes that information in real time

The consciousness angle is even bigger.

According to the theory, consciousness appears when these waves create a globally integrated state across the cortex.

One clue:
different anesthetics with very different molecular actions all seem to break the same large-scale wave dynamics — and consciousness disappears.

That suggests the common denominator may not be chemistry itself.

It may be the collapse of the brain’s wave-based coordination.

🗒 The brain is not just running code on wet hardware. It is using its own physics as the computation.
And if you want to track how your body is aging while science figures out the brain, try AgePilot bot.

By adulthood, it may already be too late to win aging just by slowing new glycation.

That’s the uncomfortable point.

Advanced glycation end products (AGEs) build up when sugars react with proteins, lipids, and other molecules.
Over time they stiffen tissues, damage blood vessels, worsen inflammation, and contribute to aging.

The problem is timing.

By the time you’re a fully grown adult, a big part of the damage may already be:
🟢 accumulated
🟢 crosslinked into long-lived tissues
🟢 hard to reverse just by blocking new formation

That’s why “anti-glycation” is often oversold.

Stopping some new AGEs from forming is useful in theory.
But if old crosslinks are already sitting in:

• arteries
• skin
• connective tissue
• kidneys
• the extracellular matrix

…then slowing the next layer of damage may not be enough.

The real challenge is bigger:
not just preventing new glycation, but dealing with the glycation that is already there.

That means the field probably needs more than:
🟠 supplements with weak anti-glycation claims
🟠 blood sugar hand-waving
🟠 generic antioxidant marketing

It needs therapies that either:

• remove damaged structures
• break harmful crosslinks
• or replace the tissues carrying the damage

🗒 The harsh truth is that aging is often easier to prevent early than to unwind later. If you want to track where your biology may already be drifting, try AgePilot bot: https://t.me/AgePilotBot?start=ref_134163805

Scientists may have created injectable “exercise” tissue that trains your body 24/7.

Chinese researchers built myografts — engineered muscle-cell constructs that can be injected under the skin, form vascularized muscle tissue, and then contract continuously on their own.

On mice, that was enough to improve:
🟢 muscle mass
🟢 physical fitness
🟢 metabolism

That’s why this is such a crazy idea.

It’s not another pill that imitates one pathway from exercise.
It’s closer to creating a living implant that behaves like permanent low-level training inside the body.

If this ever works in humans, the implications are huge:

• obesity treatment
• sarcopenia and age-related muscle loss
• metabolic disease
• recovery in people who physically cannot train

But the caveat is massive:
🟠 this is mouse data
🟠 long-term safety is unknown
🟠 uncontrolled tissue growth, immune issues, or bad integration could kill the whole idea

So no, this is not “Ozempic for the gym” yet.

But it is one of the first serious signs that future medicine may try not just to copy exercise chemistry — but to implant exercise itself.

Source:
https://futurism.com/health-medicine/chinese-scientists-develop-muscle-grafts-injected

🗒 The future of fitness may get weird fast. And if you want to track your biology before therapies like this ever reach humans, try AgePilot bot: https://t.me/AgePilotBot?start=ref_134163805

Ray Kurzweil thinks humans may “outrun aging” around 2030.

That’s the idea behind longevity escape velocity:
medical progress becomes fast enough that for every year you stay alive, science adds more than one extra year to your remaining life.

If that ever happens, aging stops being a fixed sentence and starts becoming an engineering problem.

Why people still listen to Kurzweil:
🟢 he made 140+ public predictions about tech
🟢 claims about 86% of his analyzed forecasts were broadly correct
🟢 he called things like computers beating chess champions, portable computing, and voice interfaces long before they became normal

His bigger bet is that AI + biotech + nanotech will converge.

That’s where the wild part comes in:

• AI speeds up drug discovery
• biotech gives us tools to reprogram and repair biology
• nanotech could eventually monitor and fix damage from inside the body

Kurzweil often talks about nanorobots as the long-game vision:
tiny machines moving through the body, tracking health, repairing damage, and helping fight disease from within.

That still sounds like sci-fi.

But the core thesis is less crazy than it used to be:
aging may become treatable not because of one miracle pill, but because multiple technologies start compounding at once.

Important caveat:
🟠 this does not mean immortality
🟠 it does not mean 2030 is likely
🟠 and prediction accuracy in one field does not guarantee prediction accuracy in longevity

🗒 The real shift is psychological: the question may stop being “how long can humans live?” and become “how much control can technology gain over aging itself?” If you want to track your biological age already today, try AgePilot bot: https://t.me/AgePilotBot?start=ref_134163805

The idea that breast stimulation protects women’s health is biologically interesting — but the evidence is extremely weak.

A strange old paper argues that regular breast stimulation might have protective effects through oxytocin, uterine contractions, and breast tissue physiology — potentially even affecting risks tied to breast or gynecological disease.

Why anyone takes the idea seriously at all:
🟢 breastfeeding is linked to lower risk of some cancers
🟢 nipple stimulation does trigger real hormonal responses, especially oxytocin
🟢 oxytocin has genuine biological effects on the uterus, stress, bonding, and possibly tissue function

That is the plausible part.

The weak part is almost everything else.

This was not a strong clinical trial.
It was more of a speculative theoretical synthesis built from older literature, anthropological claims, and indirect biological arguments.

So no, this is not “scientists proved massage prevents breast cancer.”

The real status is closer to:
🟠 interesting mechanism
🟠 highly stretched logic
🟠 weak evidence
🟠 no serious modern confirmation

That’s why the topic disappeared.

Not necessarily because it was false — but because it was:

• hard to test cleanly
• hard to standardize
• impossible to patent
• easy to ridicule
• overshadowed by genetics and hormone-based oncology

🗒 The useful takeaway is not the headline fantasy. It’s that some old biological hypotheses sound less crazy than they first appear — but without strong modern trials, they stay hypotheses. If you want a more grounded way to look at health and aging, try AgePilot bot

If you don’t eat enough protein, your body will slowly trade muscle for survival.

Muscle is not preserved by default — especially if you:
• get older
• train hard
• diet aggressively
• sleep badly
• move too little

That’s why protein is not just a fitness topic.
It’s a longevity topic.

The practical formula:

• 1.6–2.2 g of protein per kg of body weight per day

Examples:
• 60 kg → 96–132 g/day
• 70 kg → 112–154 g/day
• 80 kg → 128–176 g/day
• 90 kg → 144–198 g/day

The easier rule:
• aim for 30–40 g of protein per meal
• spread it across 3–4 meals per day

Why this matters:

If protein is too low, your body gets worse at:
• preserving muscle
• recovering from workouts
• maintaining strength
• staying metabolically healthy
• aging well

And after 30–40, this becomes much more important.

Because muscle loss is not just about looking worse.
It means:
• lower insulin sensitivity
• worse physical resilience
• higher frailty risk later
• lower odds of healthy aging

One more important nuance:

Not all protein is equal.

In general, animal proteins give you:
• higher protein quality
• better amino acid profile
• more leucine
• more usable protein per calorie

That doesn’t mean plant protein is useless.
It means you often need to be more intentional with it if your goal is to preserve muscle.

The real takeaway:
Don’t wait until you start shrinking, weakening, and “suddenly” feeling older.
Muscle is expensive tissue. If you don’t feed it, you lose it.

🧬 The smartest move is not just eating more protein blindly — it’s knowing your DNA and tuning your protein diet to your biology. Use my link for complete DNA sequencing

A new model says humans could live 1759 years in theory — but only about 194 if somatic mutations remain unsolved.

That’s the new longevity number making headlines.

The paper tries to estimate the theoretical upper limit of human lifespan under different assumptions.

Its most extreme scenario says:
🟢 if you could remove essentially all major aging mechanisms, lifespan might theoretically stretch to 1759 years

But in a more realistic scenario:
🟠 if somatic mutations keep accumulating and can’t be fully stopped, lifespan may be capped around 146–194 years

That’s the part that matters.

Why mutations become the bottleneck:

• many tissues can replace damaged cells
• but neurons and cardiomyocytes mostly stay with you for life
• they don’t divide much, but their DNA still gets damaged
• repair is imperfect, so mutations can accumulate over time

That makes the brain and heart the likely weak points in any future extreme-longevity scenario.

The idea is biologically plausible:
🟣 somatic mutations do increase with age
🟣 they are seen in both neurons and heart cells
🟣 across mammals, faster somatic mutagenesis tends to correlate with shorter lifespan

But the number 194 should not be treated like revealed truth.

Because the real unknown is not just how many mutations occur, but:

• which mutations matter
• how much damage a neuron can tolerate
• how much failure an organ can compensate for
• when compensation suddenly breaks

And biology is messy there.

The heart can keep working after losing cells.
The brain can compensate for damage for a long time.
Even limited renewal may still exist in some of these tissues.

So the real conclusion is narrower than the headlines:
somatic mutations may become one of the final bottlenecks to radical life extension — but “194 years” is still more model output than biological destiny.

🧬 If longevity is going to become personalized, the smartest move is to know your biology early. Use this link for complete DNA sequencing.

Higher education may be one of the strongest longevity factors humans have.

Women now outnumber men in higher education globally: 112 per 100.

In 1970, the ratio was just 59 women per 100 men.
So this didn’t just equalize. It reversed.

And that matters far beyond careers.

Because higher education is one of the strongest predictors of longer life.

More education is consistently linked to:

• lower mortality
• better health literacy
• higher income
• healthier behavior
• lower smoking rates
• better access to care
• longer lifespan

So this is not just a culture story.
It’s also a longevity story.

In many countries, women are now building an advantage not only in diplomas, but potentially in:

• health outcomes
• resilience
• future lifespan

Meanwhile, in richer countries, fewer men in university is becoming a real structural problem:
if men fall behind in education, they often fall behind in longevity too.

The map still shows two worlds:

• in poorer countries, fewer women in university often means barriers to access
• in richer countries, fewer men in university increasingly means male underperformance in the education pipeline

The long-term implication is brutal:
if education is one of the strongest longevity multipliers, then the gender gap in education may become a gender gap in healthy lifespan too.

🧬 And if you want facts instead of guesswork, you can check your sex through a DNA test — and unlock 1000+ parameters about your body. Use my link for complete DNA sequencing

Drinking water during meals does not “ruin digestion” — and soup may actually help you eat less.

The old myth says water dilutes stomach acid and makes digestion worse.

That sounds smart.
It’s mostly nonsense.

In one study, 200 ml of water raised stomach pH above 4 in most people — but only for about 3 minutes.
Then the stomach corrected it.

So yes, water briefly dilutes acid.
No, it does not meaningfully break digestion.

That also helps explain a funny effect:
some people feel relief from heartburn immediately after taking omeprazole, even though the drug itself cannot work that fast.
Part of the instant relief may just be the glass of water.

The more useful finding is about appetite.

Studies comparing meals with:

• water
• diet cola
• regular cola
• juice
• milk

found that non-caloric drinks did not increase food intake, while caloric drinks simply added extra calories on top.

Translation:
if you’re trying to lose fat, drinking calories is stupid.

Water also seems to help with weight loss directly.

In a 12-week randomized study, older adults on a low-calorie diet who drank 500 ml of water before meals lost about 2 kg more than the diet-only group.

Soup is even better.

Large population data and feeding studies suggest that soup is associated with:
🟢 lower body weight
🟢 lower obesity risk
🟢 better satiety
🟢 lower calorie intake at the meal

One simple effect matters most:
a bowl of soup before the main course can reduce total meal calories by about 20%.

That’s huge for something this boring.

The trick is obvious:

• broth-based or light soups work best
• if your “soup” is basically liquid cream and fat, congratulations, you invented a second main course

So the real rule is simple:

Water during meals is fine.
Water before meals can help weight loss.
Soup is not sacred — it’s just an effective anti-overeating tool.

🧬 And if you want facts instead of guesswork, you can check your sex through a DNA test — and unlock 1000+ parameters about your body. Use my link for complete DNA sequencing via TellMeGen

Semaglutide extended lifespan in old mice by 12.4% — but the real question is whether it slows aging or just fixes metabolic drift.

That’s the part worth arguing about.

In a new Nature study, researchers gave semaglutide to 20-month-old female mice that were already old — not diabetic, not massively obese, just aging.

Median lifespan went from 742 to 834 days.

That’s a real signal.

But there’s an immediate problem:
the mice on semaglutide also ate about 24% less.

So what actually extended life?

• the drug itself
• or plain old calorie restriction

That distinction matters.

Because on some outcomes, semaglutide looked a lot like calorie restriction:

• physical activity
• coordination
• muscle function
• endurance

But on others, it may have done better:
🟢 spatial memory
🟢 exploratory behavior
🟢 glucose control
🟢 signs of neurogenesis in the hippocampus

It also appeared to push several aging-related systems in a younger direction:

• less inflammation
• less cellular senescence
• less DNA damage
• better mitochondrial status
• better proteostasis
• a partial reversal of the age-related myeloid shift in blood stem cells

That’s why this is more interesting than another obesity headline.

The real possibility is that semaglutide may be acting not just as a weight-loss drug, but as a partial corrector of age-related metabolic and inflammatory drift.

Still, don’t oversell it.

Important caveats:
🟠 this was in mice
🟠 only females were tested
🟠 the lifespan gain was not fully disentangled from calorie restriction
🟠 834 days is not some impossible lifespan for this strain

So no, this is not proof that Ozempic is a longevity drug.

But it is one of the strongest hints yet that GLP-1 drugs may affect more than body weight — potentially touching the biology of aging itself.

🧬 The future of longevity will belong to people who measure their biology instead of guessing. Use my link for complete DNA sequencing and unlock 1000+ parameters about your body: https://shop.tellmegen.com/en?sca_ref=11848100.IoSIJUJzfNYC4

Seven new longevity signals just dropped — and most people will miss the pattern.

The big picture is simple:

Longevity is getting more programmable.
Not through one miracle drug — but through smarter control of metabolism, timing, sleep, hormones, movement, and risk management.

Here’s what matters:

1. “Smart” probiotics that release GLP-1 when glucose rises
Researchers built engineered probiotic bacteria that can sense high glucose and then secrete GLP-1.
In mice and monkeys, they helped blunt glucose spikes and turned off when sugar normalized.

That’s a wild shift:
not just taking a drug — but deploying a living metabolic sensor.

Still early. Still safety questions.
But this is the kind of thing that makes future medicine look less like pills and more like programmable biology.

2. When you start eating may matter more than fasting window size
A new NHANES-based analysis suggests that delaying the first meal too late was associated with higher all-cause and cardiovascular mortality.
Compared with starting food around 7–8 AM, waiting until after noon was linked to a 29% higher risk of death.

Not proof of causation.
But it’s another hit against the lazy idea that “any fasting schedule is equally good.”

3. The “8 hours of sleep” rule is too dumb
A new review suggests the healthiest zone for many adults may be roughly 6.4 to 7.8 hours, not a universal 8.
The real goal is not worshipping one number.

It’s:

• enough sleep
• regular sleep
• stable circadian timing

4. HRT may reduce dementia risk in some women
In 183,000+ postmenopausal women from UK Biobank, menopausal hormone therapy was linked to about:

• 10% lower dementia risk overall
• 16% lower Alzheimer’s risk

The effect looked strongest in women with surgical menopause or lower lifetime estrogen exposure.

That adds fuel to the critical window idea:
timing matters.

5. Walkable neighborhoods may cut diabetes risk
Women with prior gestational diabetes who lived in more walkable areas had about a 15% lower risk of developing type 2 diabetes.

That’s a reminder people hate:
environment is a health intervention.

A walk-friendly neighborhood can quietly outperform a lot of motivation hacks.

6. The first wearable that tracks both glucose and ketones got FDA clearance
Libre Duo 10 Day can continuously measure:

• glucose
• ketones

This matters because metabolism is finally becoming observable in real time, not guessed from vibes.

For diabetics, this is clinically useful.
For biohackers, it opens a better window into metabolic flexibility.

7. Early statins after diabetes diagnosis may lower dementia risk
A Danish study of 130,000+ people with newly diagnosed type 2 diabetes found that starting statins in the first year was linked to about a 15% lower dementia risk over 10 years.

Translation:
what protects blood vessels may also protect the brain.

The real takeaway:
The future of longevity will not be built from one “anti-aging cure.”
It will come from stacking small advantages:

• better glucose control
• better meal timing
• better sleep rhythm
• smarter hormone use
• more walkable environments
• earlier cardiometabolic intervention
• better monitoring

That’s less sexy than immortality marketing.
But it’s much closer to reality.

🧬 The winners in longevity will be the people who measure their biology instead of guessing. Use my link for complete DNA sequencing and unlock 1000+ parameters about your body: https://shop.tellmegen.com/en?sca_ref=11848100.IoSIJUJzfNYC4

“Zombie” cells don’t just sit there — they rewire their metabolism to keep inflammation on.

That’s the new Nature angle from Sanford Burnham Prebys / Mayo and collaborators.

Senescent cells leak mitochondrial signals.
Then a metabolic switch (around acetyl-CoA / DNA packaging) helps keep inflammatory SASP genes open.

🟢 In aging mice, hitting that metabolic step with CTPI-2 cut inflammation across tissues
🟢 Tissue function and healthspan markers improved
🟣 The immune leak from mitochondria was still there — but the inflammatory program got quieter

Important caveats:
🟠 mouse data
🟠 not a human therapy yet
🟠 “kill all zombies” is still too blunt — this is more like turning down their megaphone

🗒 Aging inflammation may be less “bad cells everywhere” and more bad metabolic settings that keep the alarm stuck on.

If you want a baseline on how your biology is drifting today → https://t.me/AgePilotBot

The second of the seven has a name. Navier–Stokes.

For a century the equation of flowing water refused to say whether it always stays smooth, or whether it can tear itself open.

In 2003 Grigori Perelman closed the Poincaré conjecture. The first of seven. He declined the million, and the room.

Today OpenAI claims the second.

Not the Astra in your browser. A model they called significantly more capable than GPT-6 Astra. A thousand agents on the Euler cousin. Ten thousand on the full problem. 88 hours. About $15 million if you asked to run the same search.

They say no human opened the working trace.

The Clay Institute has not stamped it. A day earlier, Buckmaster and Alpöge published the stepping-stones, and a fight over credit had already begun. The coronation is announced. The priests have not nodded.

Still. Two of seven. The first took a man who walked away. The second, if it holds, was a machine that did not look up.

https://x.com/OpenAI/status/2097374640582668336